Cytokines in alcoholic liver disease

Seminars in Liver Disease

Volumn 19, Issue 2, 1999, Pages 205-220

  McClain, Craig J ^a   Barve, Shirish ^a   Deaciuc, Ion ^a   Kugelmas, Marcelo ^a   Hill, Daniell ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Anticytokine therapy; Apoptosis; Cytokine metabolism; Cytokine receptors; Cytokines; Kupffer cells; Macrophages; Necrosis

Indexed keywords

ACETYLCYSTEINE; COLCHICINE; CYTOKINE; CYTOKINE RECEPTOR; ENDOTOXIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PENTOXIFYLLINE; PREDNISONE; PROPYLTHIOURACIL; PROSTAGLANDIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; URSODEOXYCHOLIC ACID;

ALCOHOL LIVER DISEASE; ANIMAL MODEL; APOPTOSIS; CELL DEATH; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; KUPFFER CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0032795449     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007110     Document Type: Review

References (150)

1. Hill DB, Shedlofsky S, McClain C, et al. Cytokines and liver disease. In: Remick DG, Friedland JS, eds. Cytokines in Health and Disease. New York: Marcel Dekker, 1997:401-425
2. McClain CJ, Hill DB, Marsano L, et al. A role for cytokines in alcoholic hepatitis. In: Proceedings of the 1992 Conference on Alcohol, Drugs of Abuse, and Immunomodulators (AIDS). Vol 86. New York: Pergamon Press, 1993:133-141
3. McClain CJ, Cohen DA, Dinarello CA, et al. Serum interleukin-1 (IL-1 ) activity in alcoholic hepatitis. Life Sci 1986;39:1479-1485
4. Gaetke L, McClain CJ, Talwalkar R, Shedlofsky S. Zinc metabolism in human volunteers given endotoxin as a model of gram-negative sepsis. Am J Physiol 1997;272:E952-E956
5. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 1986;163:1433-1450
6. Hill DB, Marsano LS, Shedlofsky SI, et al. Plasma interleukin-8 levels elevated in acute alcoholic hepatitis. In: Proceedings of the 1992 Conference on Alcohol. Drugs of Abuse, and Immunomodulators (AIDS). Vol 86. New York: Pergamon Press. 1993:173-177
7. Thornton AJ, Ham J, Kunkel SL, Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 1992;15:1112-1122
8. Thornton AJ, Stricter RM, Lindley I, et al. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 1990;144:2609-2613
9. Plata-Salaman CR, Borkoski JP. Chemokines/intercrines and central regulation of feeding. Am J Physiol 1994;266:R 1711-R1715
10. Mendenhall CL, Anderson S, Weesner RE, et al. Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med 1984;76:211-222
11. Sarraf P, Frederich RC, Turner EC, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 1997;185:171-175
12. Isobe H, Sakai H, Saloh M, et al. Delayed gastric emptying in patients with liver cirrhosis. Dig Dis Sci 1994;39:983-987
13. Suto G, Kiraly A, Tache Y. Interleukin 1b inhibits gastric emptying in rats: Mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology 1994;106:1568-1575
14. McCarthy DO, Daun JM. The role of prostaglandins in interleukin-1 induced gastroparesis. Physiol Behav 1992;52:351-353
15. Ott L, McClain CJ, Scheff S, et al. Cytokines in severe head injury. In: Wood, PL, ed. Neuroinflammation: Mechanisms and Management. Totowa, NJ: Humana Press, 1997:221-249
16. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994;5:517-531
17. Zamir O, Hasselgren PO, Kunkel, et al. Evidence that TNFα participates in the regulation of muscle proteolysis during sepsis. Arch Surg 1992;7:170-174
18. Matsui J, Cameron RG, Kurian R, et al. Nutritional hepatic, and metabolic effects of cachectin/TNF in rats receiving total parenteral nutrition. Gastroenterology 1993;104:235-243
19. Argiles JM, Lopez-Soriano FJ. The effects of TNFα and tumor growth on hepatic amino acid utilization in the rat. Biochem J 1990;266:123-126
20. Marsano L, McClain CJ. Nutrition support in alcoholic liver disease. In: Nutrition and Alcohol. Boca Raton, FL: CRC Press, 1992;385-401
21. John WJ, Phillips R, Ott L, et al. Resting energy expenditure in patients with alcoholic hepatitis. JPEN 1989;13:124-127
22. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80
23. McClain CJ, Barve S, Barve S, Deaciuc I, Hill DB. Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 1998;22:248S-252S
24. McClain CJ, Marsano L, Burk RF, Bacon B. Trace metals in liver disease. Semin Liver Dis 1991;11:321-339
25. Philcox JC, Coyle P, Michalska A, et al. Endotoxin-induced inflammation does not cause hepatic zinc accumulation in mice lacking metallothionein gene expression. Biochem J 1995;308: 543-546
26. Utili R, Abernathy C, Zimmerman H. Studies on the effects of E. coli endotoxin on canalicular bile formation in the isolated perfused rat liver. J Lab Clin Med 1977;89:248-253
27. Ott MT, Vore M, Barker DE, et al. Monokine depression of bile flow in the isolated perfused rat liver. J Surg Res 1989;47: 248-250
28. Whiting JF, Green RM, Rosenbluth AB, Gollan JL. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 1995;22(4 Pt 1):1273-1278
29. Green RM, Whiting JF, Rosenbluth AB, et al. Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity. Am J Physiol 1994;267(6 Pt 1): G1094-100
30. Khoruts A, Stahnke L, McClain CJ, et al. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13:267-276
31. Felver ME, Mezey E, McGuire M, et al. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990;14:255-259
32. Devicre J, Content J, Denys C, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11:628-634
33. Thiele DL. Tumor necrosis factor, the acute phase response and the pathogenesis of alcoholic liver disease. Hepatology 1989;9: 497-499
34. Hill DB, Marsano L, Cohen D, et al. Increased plasma interleukin-6 activity in alcoholic hepatitis. J Lab Clin Med 1992; 119:547-552
35. Deviere J, Content J, Denys C, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol 1989;77:221-225
36. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9:349-351
37. Bird GL, Sheron N, Goka AK, et al. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-920
38. Lee E, Marsano L, McClain CJ. Liver cytokines in alcoholic hepatitis as assessed by immunohistochemistry. Hepatology 1991; 14:A141
39. Schilling PJ, Murray JL, Markowitz AB. Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction. Cancer 1992;69:256-260
40. Shedlofsky SI, McClain CJ. Hepatic dysfunction due to cytokines. In: Kimball ES, ed. Cytokines and Inflammation. Boca Raton. FL: CRC Press, 1991:235-273
41. Grove J, Daly AK, Bassendine M, Day C. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997;26:143-146
42. Baggiolini M, Imhoden P, Detmers P. Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). In: Baggiolini M, Sorg C, eds. Interleukin-8 (NAP-1) and Related Chemotactic Cytokines. Cytokines. Vol 4. Basel: Karger, 1992:1-17
43. Paronetto F. Cell mediated immunity in liver disease. Hum Pathol 1986;17:168-178
44. Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993;18:41-46
45. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993; 18:576-580
46. Maltby J, Wright S, Bird G, et al. Chemokine levels in human liver homogenates: Associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 1996;24:1156-1160
47. Hansen J, Cherwitz DL, Allen JI. The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanolfed rats. Hepatology 1994;20:461-474
48. Adachi Y, Bradford B, Gao W, et al. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Gastroenterology 1994;20:453-460
49. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein 1 (MCP-1). Immunol Today 1990;11:97-101
50. Kunkel SL, Standiford T, Kasahara K, et al. Stimulus specific induction of monocyte chemotactic protein-1 (MCP-1) gene expression. In: Westwick J, ed. Chemotactic Cytokines. New York: Plenum 65-71
51. Hill D, Shedlofsky S, McClain CJ, et al. Cytokines and liver disease. In: Remick DG, Friedland JS, eds. Cytokines in Health and Disease. New York: Marcel Dekker, 1997:401-425
52. McClain CJ, Hill DB, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993;13:170-182
53. Verma B, Fogarasi M, Szabo G. Down-regulation of tumor necrosis factor alpha activity by acute ethanol treatment in human peripheral blood monocytes. J Clin Immunol 1993;13: 8-22
54. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987;4:8-14
55. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver diseases. Adv Pharmacol 1997;38:601-628
56. Hill DB, Awad JA. Increased urinary F2-isoprostane excretion in alcoholic hepatitis. Free Radic Biol Med 1998;(in press)
57. Lieber C. Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol Clin Exp Res 1991;15:573-592
58. Fridovich I. Oxygen radicals from acetaldehyde. Free Radic Biol Med 1989;7:557-558
59. Williams A, Barry R. Free radical generation by neutrophils: A potential mechanism of cellular injury in acute alcoholic hepatitis. Gut 1987;28:1157-1161
60. Situnayake R, Crump B, Thurnham D, et al. Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. Gut 1990; 31:1311-1317
61. Marsano L, McClain C. Nutrition and alcoholic liver disease. JPEN 1991;15:337-344
62. Mitchell MC, Raiford DS, Mallat A. Effects of ethanol on glutathione metabolism. In: Watson RR, ed. Drug and Alcohol Abuse Reviews, vol 2: Liver Pathology and Alcohol: The Humana Press, 1991
63. Pena L, Hill D, McClain C. Treatment with glutathione precursor decreases cytokine activity. JPEN 1999;23:1-6
64. Le Moine O, Marchant A, De Groote D, et al. Role of defensive monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholic cirrhosis. Hepatology 1995;22: 1436-1439
65. Border WA, Ruoslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7
66. Annoni G, Weiner FR, Zern MA. Increased transforming growth factor-beta 1 gene expression in human liver disease [see comments]. J Hepatol 1992;14:259-264
67. Matsuoka M, Pham NT, Tsukamoto H. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1989;9:71-78
68. Deviere J, Content J, Denys C, et al. Immunoglobulin A and interleukin 6 form a positive secretory feedback loop: A study of normal subjects and alcoholic cirrhotics. Gastroenterology 1992; 103:1296-1301
69. Deviere J, Vaerman JP, Content J, et al. IgA triggers tumor necrosis factor alpha secretion by monocytes: A study in normal subjects and patients with alcoholic cirrhosis. Hepatology 1991; 13:670-675
70. 4 synthesis by peripheral leucocytes in alcoholics. Gut 1989;30:1270-1274
71. Mizoguchi Y, Tsutsui H, Miyajima K, et al. The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology 1987;7:1184-1188
72. Arthur MJ. Corynebacterium parrum-elicited hepatic macrophages demonstrate enhanced respiratory burst activity compared with resident Kupffer cells in the rat. Gastroenterol 1986;91: 174-181
73. Smith S, Calzetta A, Bankowski J, et al. Lipopolysaccharide-induced cytokine production and mortality in mice treated with corynebacterium parvum. J Leuk Biol 1993;54:23-29
74. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989;38:627-631
75. Chojkier M, Fierer J. D-galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphorecticular cells in mice. Gastroenterology 1985;88:115-121
76. Lehman V, Freudenberg MA, Galanos C. Lethal toxicity cf lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987;165:657
77. Hishinuma I, Nagakawa J, Hirota K, et al. Tumor necrosis factor-α in galactosamine-induced hepatitis. Hepatology 1990;12: 1187-1191
78. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307-1316
79. Leist M, Gantner F, Bohlinger I, et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-1234
80. Bhagwandeen SB. Apte M, Manwarring L. Endotoxin induced hepatic necrosis in rats on an alcohol diet. J Pathol 1987;152: 47-53
81. Honchel R, Ray MB, Marsano L, et al. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 1992;16:665-669
82. Nanji AA, Zhao S, Sadrzadeh SM, Waxman DJ. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994;19:1483-1487
83. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995;22(4 Pt 1):1304-1309
84. Nanji A, Zhao S, Lamb R, et al. Changes in cytochromes P450, 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: Relationship to dietary fats and pathologic liver injury. Alcoholism 1994;18: 902-908
85. Nanji AA, Miao L, Thomas P, et al. Enhanced cyclooxgenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 1997;112:943-951
86. Adachi Y, Moore L, Bradford B, et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-224
87. Nanji A, Khettry U, Sadrzadeh S. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 1994;205:243-247
88. Iimuro Y, Gallucci RM, Luster MI, et al. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997;26:1530-1537
89. Shiratori Y, Takada H, Hikiba Y, et al. Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol. Hepatology 1993;18:1477-1482
90. Hisama N, Yamaguchi Y, Miyanari N, et al. Ischemia-reperfusion injury: The role of Kupffer cells in the production of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family. Transplant Proc 1995;27:1604-1606
91. Farhood A, McGuire G, Manning A, et al. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia reperfusion injury in rat liver. J Leukoc Biol 1995;57:368-374
92. Zhou W, Chao W, Levine B, Olson M. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. Am J Physiol 1992;263:G587-G592
93. Maher JJ. Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol. Am J Physiol 1995;269(4 Pt 1 ):G518-523
94. Maher JJ, Scott MK, Saito JM, Burton MC. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997; 25:624-630
95. Ross AD, Saldiva V, Oporto B, et al. Circulating neutrophils and liver injury in rat models of experimental alcoholic liver disease. Alcohol Clin Exp Res 1998;22:197-201
96. Hill DB, Shedlofsky SI, Schmidt J, et al. In vitro tumor necrosis factor cytotoxicity in HepG2 liver cells. In: Proceedings of the 1992 Conference on Alcohol. Drugs of Abuse, and Immunomodulators (AIDS), vol 86. New York: Pergamon Press, 1993:245-249
97. Hirano T, Kaplowitz N, Tsukamoto H, et al. Hepatic milochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992;16:1423-1427
98. Neuman MG, Shear NH, Bellentani S, Tiribelli C. Role of cytokines in ethanol-induced cytotoxicity in Hep G2 cells. Gastroenterology 1998;114:1-13
99. Neuman MG, Cameron RG, Shear NH, et al. Effects of tauroursodeoxycholage and ursodeoxycholic acid on ethanol-induced cell injuries in the human HepG2 cell line. Gastroenterology 1995;109:555-563
100. Neuman MG, Koren G, Tiribelli C. In vitro assessment of the ethanol-induced hepatotoxicity on HepG2 cell lines. Biochem Biophys Res Commun 1993;2:931-942
101. Deaciuc IV, Alappat MJ, McDonough KH, et al. Interleukin-6 and tumor necrosis factor alpha clearance and metabolism in vivo and by the isolated, perfused liver in the rat. Effect of acute alcohol administration. Alcohol Clin Exp Res 1996;20:293-301
102. Deaciuc IV, Alappat JM, McDonough KH, et al. Effect of chronic alcohol consumption by rats on tumor necrosis factor alpha and interleukin-6 clearance in vivo and by the isolated, perfused liver. Biochem Pharmacol 1996;52:891-899
103. Deaciuc IV, Alappat JM, D'Souza NB, et al. Tumor necrosis factor alpha internalization and degradation by isolated hepatocytes of rats exposed to ethanol. Alcohol 1998;16:125-133
104. Deaciuc IV, D'Souza NB, Spitzer JJ. Tumor necrosis factor-alpha cell-surface receptors of liver parenchymal and nonparenchymal cells during acute and chronic alcohol administration to rats. Alcohol Clin Exp Res 1995;19:332-338
105. Deaciuc IV, Alappat JM, D'Souza NB. Effect of acute and chronic alcohol administration to rats on interleukin-6 cell surface receptors of hepatic parenchymal and nonparenchymal cells. Alcohol Clin Exp Res 1994;18:1207-1214
106. Thornton AJ, Ham J, Kunkel SL. Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide. interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 1991;14:1112-1122
107. Bautista A, Spitzer J. Superoxide anion generation by in situ perfused rat liver: Effect of in vivo endotoxin. Am J Physiol 1990;259:G907-G912
108. Bautista A, Meszaros K, Bojta J, Spitzer J. Superoxide anion generation in the liver during early stage of endotoxemia in rats. J Leukoc Biol 1990;48:123
109. Wong GHW, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989;58:923-931
110. Larrick JW, Wright SC. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J 1990;4:3215-3223
111. Adamson G, Billings R. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch Biochem Biophys 1992;294:223-229
112. Stadler J, Bentz B, Harbrecht B, et al. Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration. Ann Surg 1992;216:539-546
113. Schulze-Osthoff K, Bakker A, Vanhaesebroeck B, et al. Cytotoxic activity of TNF is mediated by early damage of mitochondrial functions. J Biol Chem 1992;267:5317-5323
114. Schulze-Osthoff K, Beyaert R, Vandevoorde V, et al. Depletion of the mitochondnal electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993;12:3095-3104
115. Cunningham CC, Coleman WB, Spach PI. The effects of chronic ethanol consumption on hepatic mitochondrial energy metabolism. Alcohol Alcoholism 1990;25:127-136
116. Lauderberg B, Liang D, Schwarzenbach F, Breen K. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology 1993;17:418-422
117. Leist M, Gantner F, Bohlinger I, et al. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994;153:1778-1788
118. Nanji AA. Apoptosis and alcoholic liver disease. Semin Liver Dis 1998;18:186-189
119. Kawahara H, Matsuda Y, Takase S. Is apoptosis involved in alcoholic hepatitis? Alcohol 1994;29:113-118
120. Zhao M, Laissue J, Zimmermann A. TUNEL-positive hepatocytes in alcoholic liver disease. A retrospective biopsy study using DNA nick end-labelling. Virchows Arch 1997;431:337-344
121. Yacoub LK, Fogt F, Griniuviene B, Nanji AA. Apoptosis and Bcl-2 protein expression in experimental alcoholic liver disease in the rat. Alcoholism Clin Exp Res 1995;19:854-859
122. Wu D, Cederbaum AL. Ethanol cytotoxicity to a transfected HepG2 cell line expressing human cytochrome P450 2E1. J Biol Chem 1996;271:1-6
123. Fraser A, Evan G. A license to kill. Cell 1996;85:781-784
124. Tewari M, Dixit V. Recent advances in tumor necrosis factor and CD40 signaling. Curr Opin Gen Dev 1996;6:39-44
125. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365
126. Galle P, Hofmann W, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230
127. Galle P. Apoptosis in liver disease. J Hepatology 1997;27:405-412
128. Muschen M, Warskulat U, Douillard P, et al. Regulation of the CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 1998;27:200-208
129. Taieb J, Mathurin P, Pynard T, et al. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. Lancet 1998;351: 1930-1931
130. Baichwal V, Bacuerle P. Apoptosis: Activate NFkb or die? Curr Biol 1997;7:R94-R96
131. Sen C, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-720
132. Beg A, Sha W, Bronson R, et al. Embryonic lethality and liver degeneration in mice lacking the ReIA component of NFκB. Nature 1995;376:167-170
133. Beg A, Baltimore D. An essential role for NFκB in preventing TNF-alpha-inducedcell death. Science 1998;274:782-784
134. Doi T, Marino M, Takahashi T, et al. Absence of TNF rescues ReIA deficient mice from embryonic lethality. J Interferon Cytokine Res 1998;18:A93
135. Bellas RE, Fitzgerald MJ, Fausto N, Sonenshein GE. Inhibition of NFκB activity induces apoptosis in murine hepatocytes. Am J Pathol 1997;151:891-896
136. Iimuro Y, Nishiura T, Hellerbrand C, et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration [published erratum appears in J Clin Invest 1998 Apr 1;101:1541]. J Clin Invest 1998;101:802-811
137. Zeldin G, Yang S, Mi Y, et al. Alcohol and cytokine-inducible transcription factors. Alcohol Clin Exp Res 1996;20:1639-1645
138. Lee SY, Reichlin AM, Santana A, et al. TRAF-2 is essential for JNK but not NFKB activation and regulates lymphocyte proliferation and survival. Immunity 1997;7:703-713
139. Macfarlane JD, Bijl H, Woody JN. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-1110
140. Van Dullemen HM, Van Deventer SJ, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-135
141. McSweegan E. TNF antibodies get new lease. Nature Med 1997;3:130
142. Richardson P. Ciliary neurotrophic factor: A review. Pharmacol Ther 1994;63:187-198
143. Tracey K, Cerami A. Tumor necrosis factor and regulation of metabolism in infection: Role of systemic versus tissue levels. PSEBM 1992;200:233-239
144. Akerman PA, Cote P, Yang SQ, et al. Antibodies to tumor necrosis factor alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263:G579-G585
145. Goldblum S, Hennig B, Jay M, et al. Tumor necrosis factor-induced pulmonary vascular endothelial injury. Infect Immunol 1989;57:1218-1226
146. Ferrari-Baliviera E, Mealy K, Smith R, Wilmore D. Tumor necrosis factor induces adult respiratory distress syndrome in rats. Arch Surg 1989;124:1400-1405
147. Nelson S, Bagby G, Summer W. Alcohol suppresses lipopolysaccharide-induced tumor necrosis factor activity in serum and lung. Life Sci 1989;44:673-676
148. Nelson S, Summer W, Bagby G, et al. Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 1991;164:901-906
149. Nelson S, Bagby G, Andresen J, et al. The effects of ethanol, tumor necrosis factor, and granulocyte colony-stimulating factor on lung antibacterial defenses. Drugs Abuse Immun Immunodefic 1991:245-253
150. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NFκB-1 precursor protein and the activation of NFKB. Cell 1994;78: 773-785